Silicon Valley’s venture capital community is turning its attention to a new model for nurturing healthcare AI startups, with prominent investors backing a residency program designed to support founders at the earliest stages of innovation.
The initiative, called Treehub, was launched on April 22, 2026, by the AI Health Fund as a Stanford-adjacent residency program in Los Altos, California. It aims to fill a critical gap in the healthcare innovation pipeline by providing capital, mentorship, and resources to academic founders before their companies are formally established.
According to verified press releases and news coverage, Treehub is supported by high-profile figures in the venture capital world, including billionaire investor Tim Draper and Anne Wojcicki, founder of 23andMe. The program is structured as a six-month residency, with the first 12 weeks focused on achieving product-market fit and the final 12 weeks dedicated to company direction, such as fundraising, joining traditional accelerators, or deploying solutions in hospital systems.
Mary Minno, founding partner of the AI Health Fund and former Google product manager, announced the launch of both Treehub and its venture arm, the AI Health Fund, describing the initiative as a response to systemic challenges she observed in healthcare access and innovation. She cited personal experiences, including a family member’s acute leukemia diagnosis, as motivation for creating a pathway that empowers founders to challenge the status quo in healthcare.
The AI Health Fund writes the first check into every Treehub company, often committing capital before incorporation. Founders gain access to specialized resources not typically available through conventional funds, including medical data and insights, curated programming with industry builders, payers, and investors, and direct mentorship from entrepreneurs who have successfully built and exited multiple startups.
Addressing the Innovation Gap in Healthcare AI
Treehub positions itself as a boutique program specifically designed for early-stage founders emerging from academic ecosystems. Unlike traditional accelerators or venture funds, it focuses on the precarious phase between breakthrough ideation and fundable company formation—a stage where many promising healthcare AI concepts historically fail due to lack of capital, support, or clear pathways forward.
As stated in the program’s launch announcement, Treehub seeks to back founders who may not fit the conventional mold of Silicon Valley entrepreneurs. The initiative emphasizes that transformative healthcare companies are more likely to originate in research labs than in garages, particularly when led by scientists without prior venture experience.
By embedding itself within academic communities and offering tailored support, Treehub aims to increase the likelihood that innovations in artificial intelligence, diagnostics, and patient care transition from concept to real-world impact. The program explicitly links its mission to improving patient outcomes and addressing what it describes as a “broken healthcare ecosystem” hindered by policy limitations and outdated technology.
Backing from Established Silicon Valley Figures
The involvement of Tim Draper and Anne Wojcicki lends significant credibility to Treehub’s mission. Draper, a venture capitalist known for early investments in companies like Tesla and SpaceX, has a long history of supporting emerging technologies and entrepreneurial education through initiatives such as Draper University.
Anne Wojcicki, co-founder and CEO of 23andMe, brings deep expertise in healthcare innovation, regulatory navigation, and scaling consumer health technologies. Her participation, alongside that of her mother Esther Wojcicki—a noted educator and longtime friend of Minno—underscores the program’s intergenerational and interdisciplinary approach to fostering change in healthcare.
Esther Wojcicki’s role as a mentor and advisor reflects the program’s emphasis on guidance from experienced leaders across fields. Her background in journalism and education complements the technical and medical focus of the residency, helping founders refine their communication, ethics, and societal impact strategies.
Structure and Support for Founders
Treehub’s six-month timeline is divided into two distinct phases. The initial 12 weeks prioritize customer discovery, validation of clinical utility, and refinement of value propositions to achieve product-market fit. During this period, founders work closely with mentors to test assumptions about their target users, whether patients, providers, or payers.
The second 12-week phase shifts focus to company building and strategic decision-making. Founders explore pathways such as raising seed rounds, applying to later-stage accelerators like Y Combinator or Rock Health, or pursuing pilot deployments within hospital systems or integrated delivery networks.
Throughout the residency, participants benefit from access to de-identified medical datasets, regulatory insights, and introductions to potential clients and partners. The AI Health Fund’s role as a committed first investor reduces fundraising pressure during the program, allowing founders to concentrate on development rather than immediate financing.
Minno emphasized that Treehub’s model avoids “bolting on” academic support to traditional fund structures. Instead, the program is designed around the founder’s journey, integrating company-building resources with academic flexibility to accommodate ongoing research or lab commitments.
Implications for Healthcare Innovation
By targeting the pre-incorporation stage, Treehub attempts to solve a systemic issue in healthcare innovation: the underfunding of early-stage ideas that lack the traction or team structure required by conventional venture capital. Academic researchers, particularly those in medicine and bioengineering, often face barriers to entrepreneurship due to institutional policies, funding constraints, or lack of business training.
Programs like Treehub could increase the diversity of founders entering the healthcare AI space by lowering entry barriers for individuals without prior startup experience or extensive networks. This aligns with broader efforts to democratize innovation in sectors where entrenched incumbents and regulatory complexity can deter new entrants.
If successful, the model may inspire similar initiatives tied to other academic hubs or disease-specific research centers. Its focus on AI applications in healthcare too reflects growing investor interest in technologies that promise to improve diagnostic accuracy, streamline administrative workflows, and enable personalized treatment plans.
Next Steps and Ongoing Developments
As of April 24, 2026, Treehub has officially launched and is accepting applications from founders affiliated with academic institutions. The AI Health Fund has committed to deploying capital into selected cohorts, with the first group expected to begin the residency program in the coming months.
No public details have been released regarding the specific startups or technologies under consideration for the inaugural cohort. However, the program’s stated focus on healthcare AI suggests areas such as medical imaging analysis, predictive analytics for patient risk, AI-driven clinical trial design, and digital therapeutics may be well-represented.
Interested founders and stakeholders can find official information about application timelines, eligibility criteria, and program structure through the AI Health Fund’s public announcements and affiliated channels. Updates on cohort selections, founder progress, and early outcomes will be shared as the program advances.
For readers seeking to understand emerging models in healthcare innovation and venture support, Treehub represents a notable experiment in aligning academic excellence with entrepreneurial execution—backed by some of Silicon Valley’s most recognized figures in technology and health.